Intervention Review

You have free access to this content

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

  1. Jimmy Chong1,
  2. Bonnie Leung1,
  3. Phillippa Poole2,*

Editorial Group: Cochrane Airways Group

Published Online: 4 NOV 2013

Assessed as up-to-date: 6 JUN 2013

DOI: 10.1002/14651858.CD002309.pub4


How to Cite

Chong J, Leung B, Poole P. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD002309. DOI: 10.1002/14651858.CD002309.pub4.

Author Information

  1. 1

    Tauranga Hospital, Tauranga, New Zealand

  2. 2

    University of Auckland, Department of Medicine, Auckland, New Zealand

*Phillippa Poole, Department of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand. p.poole@auckland.ac.nz.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 4 NOV 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gilson Pires Dorneles, Priscila Vianna, Diego Del Duca Lima, Lucas Galant, Alexandre Simões Dias, José Artur Bogo Chies, Mariane Borba Monteiro, Alessandra Peres, Cytokine response to the 6-min walk test in individuals with different degrees of COPD, The Clinical Respiratory Journal, 2015, 9, 2
  2. 2
    Anthony Byrne, In people with chronic obstructive pulmonary disease, what are the effects of phosphodiesterase 4 inhibitors?, Cochrane Clinical Answers,